Morgan Stanley »

Brainstorm Cell Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.1k 31k 0.20
2023-06-30 $60k 29k 2.06
2022-12-31 $40k 24k 1.64
2022-06-30 $103k 41k 2.52
2022-03-31 $161k 49k 3.27
2021-06-30 $189k 54k 3.53
2020-12-31 $968k 213k 4.54
2020-09-30 $1.8M 108k 16.80
2020-06-30 $940k 84k 11.16
2020-03-31 $120k 26k 4.65
2019-12-31 $80k 19k 4.17
2019-09-30 $69k 18k 3.81
2019-03-31 $87k 20k 4.35
2018-12-31 $35k 9.8k 3.57
2018-09-30 $37k 9.8k 3.78
2018-06-30 $207k 53k 3.90
2018-03-31 $155k 49k 3.15
2017-12-31 $32k 8.2k 3.90
2017-03-31 $26k 6.0k 4.33
2016-12-31 $9.0k 3.5k 2.57
2016-09-30 $2.0k 1.0k 2.00
2015-09-30 $0 100 0.00